# A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System

> **NCT03397862** · PHASE1 · COMPLETED · sponsor: **Corium, Inc.** · enrollment: 256 (actual)

## Conditions studied

- Skin Irritation
- Sensitization

## Interventions

- **DRUG:** Donepezil TDS
- **DRUG:** Vehicle TDS

## Key facts

- **NCT ID:** NCT03397862
- **Lead sponsor:** Corium, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-14
- **Primary completion:** 2018-03-08
- **Final completion:** 2018-04-02
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2018-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03397862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03397862, "A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03397862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*